AMS
0.012
140%
4DS
0.01
-64.3%
PLG
0.024
140%
AGN
0.245
-62%
MDI
0.046
130%
CNJ
0.004
-42.9%
4DX
1.545
99.4%
MGU
0.008
-33.3%
ABX
0.077
79.1%
TMK
0.002
-33.3%
MRQ
0.005
66.7%
LML
0.007
-30%
RCR
0.021
61.5%
BKT
0.019
-29.6%
FBM
0.038
58.3%
JAY
0.005
-28.6%
KRR
0.011
57.1%
PPY
0.01
-28.6%
SP3
0.032
52.4%
MGT
0.065
-25.3%
JAV
0.003
50%
1AD
0.003
-25%
ZMM
0.018
50%
ECS
0.006
-25%
LAT
0.065
44.4%
ITM
0.048
-25%
SNS
0.069
43.8%
XGLR
0.003
-25%
FXG
0.275
41%
VML
0.175
-23.9%
CTO
0.007
40%
BMM
0.19
-22.4%
GMN
0.092
39.4%
ESR
0.028
-22.2%
NNL
0.125
38.9%
GTN
0.27
-21.7%
DUG
2.17
37.3%
KTA
0.011
-21.4%
CAE
0.037
37%
AHK
0.345
-20.7%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

LBT Innovations (ASX: LBT): Completes first sale of APAS® PharmaQC

Australian medical technology company LBT Innovations (ASX: LBT) has completed its first sale of APAS® PharmaQC to Thermo Fisher Scientific (Thermo Fisher), aiming to provide efficiencies and improve traceability within environmental monitoring workflows using AI | ASX announcement: https://announcements.asx.com.au/asxpdf/20240222/pdf/060pf49b9csjfg.pdf